CKS2 and hepatocellular carcinoma: In addition, CKS2 has already been reported as a prognostic indicator in HCC, and G6PC has been validated as a prognostic biomarker in KIRC.[35,36] Hence, we chose G6PC instead of CKS2 for further verification in HCC and other tumor types.